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foreword by the british heart foundation (bhf)
Through its Annual Statistical Report, NACR provides important new insights on  
the performance and patient outcomes of cardiac rehabilitation (CR) programmes.  
This enables CR teams, NHS providers, commissioners and policy makers to evaluate  
progress, share best practice and build momentum in preventing cardiovascular disease. 
The 2017 report is no exception. NACR has increased coverage – exceeding 100,000 
registered patients for the first time – and represents a more accurate picture of the 
diversity of patients being treated for cardiovascular diseases. The age of patients 
receiving CR ranges from 18 to 108 – a much broader population than those studied  
in CR clinical trials. This lends weight to the evidence for CR and presents an  
opportunity and a challenge for programmes to consider the different needs  
of patients when designing services.
The BHF is encouraged to see that more than half of eligible patients are now taking 
up CR – a world-leading level of participation. However, the 2017 report highlights 
considerable performance differences between countries, Health Regions and 
individual programmes in meeting BACPR national minimum standards. Programme 
or site-level differences in duration of rehabilitation and inconsistencies in pre- and 
post-assessment practices are cited as likely contributing factors. The increasing 
ability of NACR to drill down into these data at local and Health Region level will help 
commissioners and providers of CR better understand barriers to uptake and develop 
interventions to improve service quality.
We also welcome the additional breakdown in this year’s report by gender and age, 
improving understanding of why some patients do not participate in or complete 
CR. With a large proportion of eligible patients still not taking up the offer of CR, it will 
be crucial to understand perceptions, preferences and barriers to improve uptake. As 
highlighted last year, group-based CR remains the primary delivery mode. The BHF 
strategy involves working with Health Regions to support innovative forms of CVD 
prevention delivery – and we look forward to opportunities to pilot new home, web-  
and community-based CR interventions that better take account of age, gender  
and ethnicity.
NACR is showing where timely referrals and achieving CR national standards results 
in optimal patient outcomes, strengthening the case for NHS provision of CR. 
Improvements in uptake and delivery are only possible thanks to the dedication, 
expertise and skills of the individual members of the multidisciplinary CR teams across 
England, Northern Ireland and Wales. I would also like to acknowledge and thank the 
team at the University of York and colleagues at NHS Digital for producing the quality 
data needed to measure progress. 
We fully endorse the renewed recommendation that programmes use the NACR 
resource to assess their status in respect of achieving national certification. We look 
forward to working with NACR and the BACPR to achieve the other recommendations 
highlighted in this report and build further on this success.
 
dr Mike Knapton, associate Medical director, british heart foundation 
Catherine Kelly, director – Prevention, Survival and Support, british heart foundation
The bhf is encouraged to see that more 
than half of patients eligible for Cr are now 
taking up this service.
2017 
2016
2015
reGiSTered PaTieNTS
101,423
+6.6%
101,423
95,181
86,170
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Prevention and rehabilitation (baCPr)
The BACPR is very much encouraged by the increase in uptake of CR to over 50%  
this year, which UK clinical programmes should be very proud of. This represents  
one of the highest uptake figures globally. We also welcome how NACR is focusing 
on the quality of service delivery and outcomes, which aligns with our shared vision 
to improve UK services for the benefit of patients. 
The proportion of patients completing CR (77%) is equivalent to the completion 
rates seen in well-resourced clinical trials. With NACR now reporting on the ‘reasons 
for not taking part or completing CR’, we have identified a ‘lack of interest’ as being 
the prime barrier to improving uptake further. The challenge now for clinical teams  
is to engage this uninterested patient population and find ways to motivate them  
to start what is a fundamental part of their cardiovascular care. 
More patients than ever are now registered with NACR, providing extensive coverage 
of the NHS patient population. With this knowledge, we can see that recruitment 
of eligible female patients is lower than expected for many local programmes. The 
number of heart failure patients starting CR in this audit year was 4,723, which makes 
up 5.3% of the total patient population receiving CR. 
Group-based CR remains the dominant mode offered by programmes, which is 
taken up by around 82% of patients, with close to 10% taking up home-based and 
a smaller amount (1%) taking up structured online options. The remainder (7%) are 
using other undefined modes such as telephone support. A greater range in the 
modes of delivery offered by all programmes is required to make a step change 
in uptake in the coming years. The BACPR education and training courses are 
constantly being updated so that CR programme staff can acquire the skills and 
competencies to offer a wider evidence-based menu for the mode of delivery. 
In this year’s report 83% of patients started their programme with a baseline 
assessment, which is a four percentage point improvement on last year. Importantly, 
more patients are receiving assessments at the end of CR with 62% of patients 
starting CR having a follow-up assessment. This year, 2,851 more patients had  
a post-CR assessment and while this is encouraging this result is weakened by the 
knowledge that 7,128 patients completed CR without an assessment. Not having  
a post-CR assessment not only fails to align with BACPR minimum standards but  
it also means that patients do not obtain a long-term management goal or plan.
The level of variation in CR programme design and service delivery in this year’s 
NACR report reiterates the need for local programmes to seek national accreditation 
through the BACPR/NACR National Certification Programme for CR (NCP_CR). 
Benchmarking the extent by which your programme meets the minimum standards 
can only foster a desire for improvement. Please contact the BACPR and NACR about 
registering for the NCP_CR. 
 
dr Scott Murray, President, baCPr 
Sally hinton, executive director, baCPr
The proportion of patients completing  
Cr is equivalent to the completion rates seen 
in well-resourced clinical trials.
2017 
2016
2015
ToTal uPTaKe
51%
+1%
51%
50%
47%
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NaCr executive Summary
This year, CR patient numbers registered with NACR have exceeded 100,000 
suggesting greater coverage and representation of the eligible populations. 
The age of patients receiving CR ranged from 18 to 108 years, with a mean 
age of 70 years for females and 66 years for males. Although the number 
of females within NACR is up by 1,472 on last year the proportion of the 
total remains at just under 30%, which is slightly lower than last year. The 
multi-morbid profile of CR patients is increasing across a range of different 
conditions, dominated by hypertension at 63%.
This is the second year of reporting at named local programme level informing 
the Annual Statistical Report on CR for England, Northern Ireland and Wales. 
Across the three nations more patients, from all diagnostic groups, are receiving 
CR than previously with a total for the UK of 87,827 patients in this year. 
The percentage of patients that start and then finish core CR is 77%, which 
represents a positive situation for the UK. We have also shown for the first time 
that the reasons for not completing CR vary depending on age. 
Group-based CR dominates the mode of delivery across age, gender and 
diagnosis (range 64% to 85%) with a slightly higher proportion of males  
on average (78%) carrying out group-based compared to females (75%). 
Home-based CR was the next highest mode of delivery at 13.5%, especially  
in male and female patients aged 75 and above. The average (median) UK 
duration of CR is nine weeks which is above the minimum standard (eight 
weeks) and 58% of patients met this requirement. 
Tangible gains are evident based on last year’s report and its 
recommendations. This year 83% of patients that started CR had a baseline 
assessment, which is a four percentage point improvement on last year. 
Building on last year’s report, which set a recommendation of more patients 
receiving assessments at the end of CR, we can share further success with 
62% of patients starting CR having a follow-up assessment, which is a six 
percentage point increase on last year (2,851 more patients). Notwithstanding 
these improvements, based on this year’s audit data, 7,128 completed  
CR without an assessment, which fails to align with BACPR and numerous 
clinical guidance/position statements which recommend pre- and post-CR 
assessment.
This year’s annual report has compared service delivery to six standards 
which are similar to those in a recent paper and the BACPR core components 
(Doherty 2017, BACPR 2017). Two standards have reached an agreed minimum 
standard, delivering to priority groups and duration, which more than half 
of each country’s programmes are meeting (≥50%). Regarding the other 
four standards NACR has utilised country specific averages and has reported 
against these. The presentation of this data indicates variation in regional 
service delivery quality but also highlights a need for greater NACR data entry, 
a core component of the BACPR standards (BACPR 2017).
ProGraMMeS are aCCePTiNG all TYPeS 
of PaTieNTS: ThiS Year More ThaN Three 
QuarTerS aCCePTed all fiVe PrioriTY 
GrouPS. 
100%
briTiSh hearT fouNdaTioN
Wales
100%
England
85%
Northern Ireland 
75%
This year 83% of patients that started Cr had 
a baseline assessment, a four percentage point 
improvement on last year.
9KeY reCoMMeNdaTioNS:
1.  Programmes should aim to recruit a greater proportion of eligible female patients. 
2.  A much bigger proportion of eligible heart failure patients should be referred  
to CR and supported to take up the offer.
3.  A greater range of modes of delivery, beyond just group-based, should  
be offered to patients. 
4.  Assessment of patients who complete CR should be at 100%. 
5.  The duration of CR should meet the minimum requirement of eight weeks.
6.  Programmes should seek to have their service accredited as part of the  
National Certification Programme for CR.
We wish to thank CR teams for their efforts in the delivery of services to patients  
and for supplying data to NACR, which is essential to achieving our shared aim  
of high-quality CR.
rePorT MaiN auThor: ProfeSSor PaTriCK doherTY  
(direCTor of NaCr)  
 
Co-auThorS iNClude: 
t $PSJOOB1FUSF/"$31SPKFDU.BOBHFS
t /FSJOB0OJPO/"$35SBJOJOHBOE*OGPSNBUJPO0GGJDFS
t "MFY)BSSJTPO)FBMUI4FSWJDFT3FTFBSDIFS	"OBMZTU

t +FTT)FNJOHXBZ,BSFO$BSEZ"VEJUBOE3FTFBSDI4FDSFUBSJFT
t -BST5BOH*OUFSOBUJPOBM/"$33FQSFTFOUBUJWF
The BHF National Audit is hosted at the Department of Health Sciences,  
University of York, UK. For further information and contact details please visit  
www.cardiacrehabilitation.org.uk
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The CoVeraGe of uK Cr 
ProGraMMeS eNTeriNG daTa
74%
NuMber of PaTieNTS 
reGiSTered iN 2015-16
>100k
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The BHF and NACR, working in collaboration with the BACPR and national 
associations in England, Northern Ireland, Scotland and Wales, are collectively 
committed to ensuring that all patients receive the highest quality of care 
and achieve similar benefits no matter where they live.
For Cardiac Rehabilitation (CR) this is accomplished by comparing data 
collected by NACR, ideally from all programmes in the UK, with agreed 
national ‘minimum standards’ on how best to deliver CR (BACPR 2017). 
NACR is the only national audit collecting data on the quality of care and 
clinical outcomes for patients taking part in CR following a Myocardial 
Infarction (MI), Percutaneous Coronary Intervention (PCI) and Coronary Artery 
Bypass Graft (CABG). To fulfil this role NACR needs to collect data from routine 
clinical practice about the type of service offered and the typical benefits 
patients achieve. To gain the best possible picture we ideally need data from 
all eligible patients who are offered CR. The data that NACR collects serves  
two purposes. Firstly, to support local hospital or community-based CR teams 
to generate their own local reports about patient progress and secondly, 
to enable the national audit to monitor and help improve the quality of CR 
services across the UK. The data seen by the national audit team does not 
contain personal details of patients.
The recommendations from NICE Clinical Guidance (CG172, CG94 and CG108) 
and leading British and European cardiovascular professional associations 
(BACPR 2017, Piepoli et al 2012, SIGN 2017), reinforced by the most recent 
systematic reviews (CROS 2017, Anderson et al 2016, Taylor et al 2014), are 
that CR is effective and should be offered to all eligible patients in a timely and 
appropriate manner. Set against the rapidly changing nature of cardiology 
and associated innovation in service delivery, some forms of CR in routine 
practice are arguably less effective in the modern era (West et al 2011, Wood 
%PIFSUZ-FXJO%BMBMFUBM

introduction
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The most recent clinical review of CR published in the British Medical Journal 
(Dalal et al 2015) highlights that CR is highly effective but warns that not 
all programmes are working to the minimum standards. NACR now has 
sufficient data and statistical power to report national, regional and local 
performance against agreed minimum clinical standards (BACPR 2017). 
NACR also generates routine reports used by clinicians, providers and 
commissioners to evaluate service provision. Local programmes are able 
to generate similar reports from their data, for their service. A recent paper, 
using NACR local reporting functions and hospital readmission data, has 
produced programme level evidence that CR represents a viable business 
DBTF	(PSF%PIFSUZ

In 2017, NACR reports against agreed minimum standards locally and  tests 
the extent by which services deliver quality CR (Furze 2016). For the second 
year running the report will present the extent of patient outcomes at a 
local service level. Continued debate in the research literature suggests that 
routine clinical practice might be sub-optimal and may not be deriving the 
FYQFDUFEPVUDPNFT	8FTUFUBM%PIFSUZ-FXJO
5IFSFJTBMTP
huge variability in what constitutes CR in routine practice, prompting the 
BACPR to set basic minimum standards. Data from routine clinical practice 
(NACR 2015) showed that CR is (1) being delivered later than recommended 
(2) is not underpinned by pre- and post-assessment and (3) is shorter in 
duration than the evidence would suggest is effective (Anderson et al 2016, 
NICE 2013, Piepoli et al 2012, Vanhees et al 2012). 
The NACR 2017 report shows the extent by which CR programmes meet 
the agreed clinical minimum standards and sets out the typical outcomes 
achieved by patients following CR at a local programme level.
The NaTioNal audiT of CardiaC rehabiliTaTioN  
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ParT oNe: iNTroduCTioN aNd MeThodS
Methods for collecting data for NaCr  
annual Statistical report
Registration and data input through NACR is one of the six BACPR national minimum 
standards, which aim to use audit data to quality assure CR delivery and drive service 
improvement (BACPR 2017). NACR uses a quality approach with extensive data checking 
and validating, which has reduced the burden of matching and cleaning audit data. 
Through our work with NHS Digital and representatives from England, Northern Ireland 
and Wales we have aligned data collection with key indicators, such as timing and duration 
of CR, across regional health boundaries. We continue to work with clinical leaders in 
Scotland to complete a feasibility study of CR data collection that will hopefully result in 
their inclusion in NACR in the near future. The NACR 2017 report uses data from 2015-2016 
and reports CR uptake for patients following MI, MI + PCI, PCI and CABG across England, 
Northern Ireland and Wales. 
NuMber reCeiViNG Cr
Detail about the number of patients receiving CR was achieved by collating data from 
the NACR electronic database and via the NACR postal survey. Where programmes did 
not provide data the numbers of patients receiving CR were estimated using either the 
previous year’s figures for that site (if they confirmed that the service had not changed),  
or using the average number calculated from those sites that had returned data.
NuMber eliGible for Cr
Uptake was calculated for four diagnosis groups; MI, MI + PCI, PCI and CABG. In order  
to avoid double counting, patients with an MI and CABG in the same year were counted in 
the CABG group. Due to national coding variations in reporting of Heart Failure (HF) patient 
numbers, the audit was unable to derive valid numerator and denominator values across 
the nations of the UK for this diagnosis.
eNGlaNd
NHS Digital provided individual anonymised patient level Hospital Episode Statistics (HES) 
data on the number of people with a diagnosis of MI and treatment codes of PCI or CABG. 
Those with death on discharge recorded were excluded.
NorTherN irelaNd
The Department of Health provided aggregated data on people discharged alive after 
having an MI, MI + PCI, PCI or CABG.
WaleS
NHS Wales Informatics Service provided aggregated data on people discharged alive after 
an MI, MI + PCI, PCI or CABG. 
oTher CouNTrieS
This includes the Isle of Man and the Channel Islands, which are reported in terms of key 
service indicators and outcomes where applicable.
15
approval process for accessing 
NhS data for NaCr
NACR, through NHS Digital, has approval (under Section 251 of the NHS Act 2006) from 
the Health Research Authority’s Confidentiality Advisory Group (CAG) to collect patient 
identifiable data without explicit consent from individual patients. The challenge of gaining 
patient consent, to use their data for national audit purposes, is extremely difficult and 
would create a huge burden on services and staff during the management of a heart attack 
or immediately following surgery. For this reason the NHS has in place an ‘exemption from 
consent’ process where clinical and personal data is entered into NHS systems without 
explicit consent. Patients are informed about the purposes of the audit and how the 
information will be used through face to face communication, and through the assessment 
questionnaires that are used to collect data for the audit. There is information on the front 
of these questionnaires to provide patients with details of why the data is being collected, 
how it is used, who can see it, and their right to opt out without any effect on their 
treatment. The Section 251 approval covers the roles of the BHF, NHS Digital and the NACR 
team and ensures the highest quality procedures for collecting, sharing and using only the 
agreed data about a patient’s CR experience. The approval and the role of the national audit 
are reviewed each year by CAG.
For more information about NACR please visit our web pages. 
The Cardiovascular Health Research Group  
www.york.ac.uk/healthsciences/research/cardiac 
www.cardiacrehabilitation.org.uk 
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aVeraGe uPTaKe iN uK  
iN 2015-16
51%
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Table 1:  
NuMber aNd TYPe of PaTieNTS STarTiNG Cr
NuMber of PaTieNTS
eNGlaNd NorTherN irelaNd WaleS oTher
MI  14,182  363  730  42 
MI + PCI  23,554  985  1,506  96 
MI + CABG  1,945  69  151  27 
CABG  9,248  363  531  30 
PCI  13,893  554  480  45 
MI with HF  170  3  7  2 
HF  4,313  46  174  8 
Angina  2,362  127  526  7 
Valve Surgery  4,186  137  340  13 
Other Surgery  445  9  44  - 
Cardiac Arrest  111  -  3  1 
Pacemaker  248  3  19  6 
Implantable Cardioverter Defibrillator  578  11  28  6 
Other  2,850  136  406  2 
Unknown  1,661  5  40  - 
TOTAL  79,746  2,811  4,985  285 
Based on data from NACR electronic data entry and the NACR annual survey of programmes. 
ParT TWo: uPTaKe To CardiaC rehabiliTaTioN bY CouNTrY
Programmes continue to offer CR to more patients than ever within the eligible groups of  
post-MI, MI + PCI, PCI and CABG, which represent the conventional CR population. This is 
followed by HF and valve surgery patients, who are increasingly accessing services (Table 1). 
In 2013, the NHS England CVD Outcomes Strategy (2013) set an ambition of 33% uptake  
of CR in patients with HF. We are starting to see HF patient numbers increase, with over 90% of 
programmes now offering CR to these patients, which is a marked difference compared to 2010 
when less than 30% of programmes included these patients. Data from the National Cardiology 
HF Audit run by the National Institute for Cardiovascular Outcomes Research (NICOR) suggests 
that between 7% and 20% of patients with a HF diagnosis are referred to CR from general or 
cardiology wards with wide variation in referrals between hospitals. Survival analysis of patients 
with HF, who are referred to CR, demonstrated improvements of 12% compared to patients not 
referred to CR (National Heart Failure Audit, NICOR 2017). 
Looking forward, as the National Heart Failure Audit does not collect details on actual CR or 
patient outcomes following CR, NACR is increasingly taking on this role and will report more 
on HF CR delivery and outcomes in the next two years. 
Optimal referral mechanisms will be required if the NHS England uptake target for HF is to  
be achieved. But our data on mode of delivery for CR suggests that older patients generally,  
and particularly those with HF, require a more tailored approach to find CR attractive. This is  
an area where additional work by programmes and commissioners of healthcare will be needed 
to develop suitable modes of CR delivery for this distinctive population. CR programmes will 
be encouraged and supported by NACR, BHF and BACPR to pursue innovative service designs 
based on a strong clinical business case so that ‘all eligible patients’ can access CR. The BHF 
Alliance also supports health professionals to apply best practice in service delivery and learn 
from each other.  
 
Learn more at: www.bhf.org.uk/bestpractice
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Mi % 
17
Mi + PCi % 
30
PCi % 
17
hf % 
5
CabG % 
14
oTher % 
16
Proportion of conventional evidence 
based patients starting Cr
17%
17%
14%
5%
16%
30%
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ParT TWo: uPTaKe To CardiaC 
rehabiliTaTioN bY CouNTrY
uptake to Cr services
uK
NACR 2017 is pleased to show that the overall mean uptake to CR in the UK continues to 
achieve internationally leading levels at 51%. CR practitioners should be proud of the part 
they have played in making this possible. However, this is not a time to be complacent,  
as the UK remains short of national uptake recommendations for England (Cardiovascular 
Disease Outcomes Strategy CVDOS 2013), Northern Ireland (CREST 2006), Scotland  
(SIGN 2017) and Wales (All Wales Cardiac Rehabilitation Review 2013).
In 2015-16, over 133,000 patients from conventional evidence-based CR populations were 
deemed eligible for CR in England, Northern Ireland and Wales (Table 2). The recruitment of 
these patients has improved with 6,242 more events in the audit compared to the previous 
year when all patient types are considered (Table 5). 
The total number of patients taking up CR increased by 2,942, which represents a 
significant improvement on last year. This shows that programmes are being more inclusive 
of NICE and BACPR patient groups. Programmes have shown a year-on-year increase  
in their ability to recruit patients on the MI + PCI, PCI and CABG treatment pathway  
(Table 2), which has clearly helped push the UK to internationally leading levels of uptake. 
It would appear, however, that improvements in CR recruitment associated with cardiology 
intervention pathways (PCI or surgery) comes at a cost for patients on alternative pathways 
of care. Across all nations, uptake for post-MI patients (e.g. those treated with medication 
only) remains a concern with less than 40% of all eligible patients on this care pathway 
taking up the offer of CR. 
eNGlaNd
Uptake to CR in England has improved by three percentage points and now stands at 52% 
of eligible patients across the four diagnosis/treatment groups receiving CR, with 3,032 
more patients treated compared to last year (Table 2). The main increase is for PCI and 
CABG with seven percentage point and five percentage point greater uptake respectively. 
Uptake in post-MI patients has once again dropped by one percentage point compared  
to last year.
NorTherN irelaNd
The proportion of patients taking up CR in Northern Ireland is mixed with a nine 
percentage point increase in patients following MI + PCI achieving a specific uptake value 
of 64%. However, there was a 13 percentage point drop in the proportion of patients on 
a conservative post MI pathway taking up CR. Overall there was a three percentage point 
drop in CR uptake (44% to 41%) from last year.
WaleS
CR uptake in Wales has dropped by eight percentage points from 59% to 51%  
which can be attributed to an eight percentage point drop in patients following MI and  
a nine percentage point drop in patients on a planned PCI pathway. There was a four 
percentage point increase in patients on a MI + PCI pathway which led to an overall 96% 
uptake for this patient group. However, the total number of patients seen across Wales has 
increased by 40 this year, which combined with the previous increase from 2015 shows  
a cumulative rise of 377 patients.
21
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Table 2:  
Cr uPTaKe SPliT bY CouNTrY aNd MaiN diaGNoSiS/TreaTMeNT GrouP
CouNTrY N reCeiViNG Cr uPTaKe %
Total UK MI 41,464 15,275 37
MI + PCI 43,979 26,045 59
PCI 29,434 14,927 51
CABG 19,021 12,307 65
Total 133,898 68,554 51
England MI 36,433 14,182 39
MI + PCI 40,872 23,554 58
PCI 26,495 13,893 52
CABG 17,699 11,193 63
Total 121,499 62,822 52
Northern Ireland MI 1,779 363 20
MI + PCI 1,533 985 64
PCI 1,852 554 30
CABG 534 432 81
Total 5,698 2,334 41
Wales MI 3,252 730 22
MI + PCI 1,574 1,506 96
PCI 1,087 480 44
CABG 788 682 87
TOTAL 6,701 3,398 51
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ParT Three: 
NaCr STaTiSTiCS bY CouNTrY, 
healTh reGioN aNd loCal 
ProGraMMe leVel
CoVeraGe of rePorTiNG iN 
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Countries
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Health Regions
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CR Programmes
224
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Table 3:  
CouNTrY aNd healTh reGioN rePorTed iN NaCr
CouNTrY   healTh reGioN NaCr reGioNal abbreViaTioNS 
England Cheshire and Merseyside $.
East Midlands EM
East of England E o E
Greater Manchester, Lancashire and South Cumbria (.-4$
London L
Northern England NE
South East Coast SEC
South West SW
Thames Valley TV
Wessex W
West Midlands WM
Yorkshire and The Humber :5)
Northern Ireland Belfast Health and Social Care Trust BHSCT
Northern Health and Social Care Trust NHSCT
South Eastern Health and Social Care Trust SEHSCT
Southern Health and Social Care Trust SHSCT
Western Health and Social Care Trust WHSCT
Wales Abertawe Bro Morgannwg ABM
Aneurin Bevan AB
Betsi Cadwaladr BC
Cardiff and Vale $7
Cwm Taf CT
Hywel Dda HD
Powys Teaching PT
Other (Isle of Man and  
Channel Islands)
– –
– –
ParT Three: NaCr STaTiSTiCS bY CouNTrY, healTh reGioN 
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NACR reports to local programme level as well as the 24 Health Regions for England, 
Northern Ireland and Wales shown in Table 3 below (abbreviated as indicated throughout 
the report).
25
Cr programme data by country and health region
It is encouraging to report that 74% of programmes are now entering data electronically 
(224 of all programmes), which is an increase from last year, and is enabling greater 
audit coverage. Northern Ireland and Wales have very high and consistent data entry 
performance whereas there are large variations between Health Regions in England 
(Table 4). By combining data from Tables 1 and 4, we can see that the average number 
of patients starting CR per programme in the UK is 290, with a per country breakdown 
of 306, 187, and 208 for England, Northern Ireland and Wales, respectively. 
Table 4:  
Cr ProGraMMe daTa bY CouNTrY aNd healTh reGioN
CouNTrY healTh reGioN CCG* 
NuMber
ToTal 
ProGraMMeS
eleCTroNiC 
NaCr daTa
% eNTeriNG 
daTa
England $. 12 12 11 92
EM 20 22 15 68
E o E 19 27 23 85
(.-4$ 20 24 20 83
L 32 36 23 64
NE 11 21 4 19
SEC 20 22 18 82
SW 11 25 18 72
TV 10 6 6 100
W 9 7 7 100
WM 22 28 20 71
:5) 22 31 20 65
Northern Ireland BHSCT N/A 3 3 100
NHSCT N/A 4 4 100
SEHSCT N/A 3 3 100
SHSCT N/A 3 3 100
WHSCT N/A 2 2 100
Wales ABM N/A 4 4 100
AB N/A 4 4 100
BC N/A 4 4 100
$7 N/A 2 2 100
CT N/A 2 2 100
HD N/A 4 4 100
PT N/A 4 3 75
Other 3 3 1 33
TOTAL 303 224 74
NB: CCG* Clinical Commissioning Groups.
PT (Powys Teaching Health Board) has been removed from future tables due to insufficient NACR data. 
See Table 3 for abbreviations
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age and gender profile at country, health region  
and programme level
ParT Three: NaCr STaTiSTiCS bY CouNTrY, healTh reGioN 
aNd loCal ProGraMMe leVel
There were 6,242 more patient events registered on NACR compared to last year, reaching 
a total of 101,423. This is the first year these have exceeded 100,000 – making NACR 
increasingly representative of the eligible population, and suggesting that findings from  
the annual report are more likely to reflect clinical practice.
The most recent Cochrane Review of CR effectiveness by Anderson et al (2016) is based on 
patients with a mean age of 56 years (range from 49 to 71) whereas the patient population 
seen in routine practice, as captured by NACR, has an average age of 67 years (18 to 108).  
The number of patients above 75 years of age entered into the audit was 12,248 which  
once again reiterates the difference to the Randomised Controlled Trials research population, 
where virtually no patients above 71 years were recruited. UK CR programmes should  
be commended for the age range of patients recruited which clearly encompasses  
the Cochrane age ranges but more importantly extends to younger and older patients.
Table 5: 
NaCr deMoGraPhiCS for aGe aNd GeNder bY CouNTrY aNd healTh reGioN 
Male feMale aGe
CouNTrY healTh reGioN N aGe % aGe % MiNiMuM MaXiMuM
England $. 6,386 66 67 70 33 18 101
EM 7,455 66 71 69 29 18 100
E o E 8,138 67 72 72 28 18 101
(.-4$ 13,055 65 68 70 32 18 104
L 15,796 63 71 68 29 18 96
NE 296 66 66 69 35 30 97
SEC 7,416 66 71 71 29 18 100
SW 6,962 67 72 71 28 18 100
TV 2,608 66 75 70 25 18 100
W 6,788 67 70 71 30 18 99
WM 6,430 66 69 71 31 19 108
:5) 6,906 65 70 70 30 21 101
Total 88,236 66 70 70 30 18 108
Northern Ireland BHSCT 1,476 64 73 68 27 18 94
NHSCT 906 67 69 71 31 21 93
SEHSCT 1,073 65 74 69 26 22 96
SHSCT 896 64 72 69 28 26 91
WHSCT 492 64 75 66 25 34 92
Total 4,843 65 73 68 27 18 96
Wales ABM 1,123 66 69 69 31 20 95
AB 1,063 65 69 67 31 23 97
BC 2,351 66 67 69 33 20 101
$7 1,176 65 67 68 33 20 92
CT 628 65 67 68 33 26 95
HD 1,130 67 64 70 36 18 95
Total 7,471 66 67 69 33 18 101
Other 111 64 67 64 33 29 86
TOTAL 101,423 66 70 70 30 18 108
See Table 3 for Health Region abbreviations
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On average, across all three nations, the proportion of females and males accessing CR 
remains roughly the same as last year at around 30% and 70% respectively, although 
considerable variation exists within each country (Table 5, Figure 1 a-c). The proportion  
of women below 75 years accessing CR was 25%, versus 40% for women above 75 years  
of age. This variability highlights the requirement for programmes to tailor the CR 
intervention using a wider range of core components to better meet the needs of patients 
of different ages and gender (Al Quait and Doherty 2016). Further variability is seen in 
the ability of programmes to recruit women between countries with England (Figure 1a) 
showing a range of 18.8% to 47.6%, Northern Ireland 16.5% to 30.1% (Figure 1b) and Wales 
24.8% to 38.4% (Figure 1c).
fig 1a. 
eNGlaNd
fiGure 1 a-c: ProPorTioN of Male aNd feMale PaTieNTS bY aGe aNd CouNTrY/ProGraMMe
fig 1b. 
NorTherN irelaNd
fig 1c. 
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ethnicity, employment and marital status
The ethnicity of patients attending CR remains predominately White-British and male 
(Table 6) although there is variability at regional and at a local programme level. Variation 
in ethnic profile may have implications for how CR programmes are resourced (e.g. 
translation and interpreter costs). NACR has produced an online supplement showing local 
level variation in ethnicity available from http://www.cardiacrehabilitation.org.uk/current-
annual-report.htm
Table 6:  
eThNiCiTY bY GeNder
eThNiCiTY  % Male % feMale %
White British 79 70 30
Irish 1 69 31
Any other White background 3 73 27
Mixed White and Black Caribbean <1 61 39
White and Black African <1 72 28
White and Asian <1 74 26
Any other mixed background <1 73 27
Asian or Asian British Indian 3 74 26
Pakistani 2 75 25
Bangladeshi 1 78 22
Any other Asian background 1 77 23
Black or Black British Caribbean 1 57 43
African <1 65 35
Any other Black background <1 73 27
Other Chinese <1 71 29
Any other ethnic group 1 73 27
Not stated 6 72 28
TOTAL 100 71 29
N = 81,043
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Being married remains the dominant social status demographic of CR at 68% and the 
remaining categories range from 3% to 10% for the other marital status groups (Table 7). 
The dominant employability demographic is retired (56%), followed by employed at 28% 
when part-time and full-time employment are combined (Table 8). 
The BHF research group in York recently published a paper, using CR completion data  
from NACR, which showed that employment status – in this case ‘being unemployed’ –  
was associated with poorer outcomes following CR (Harrison et al 2016). 
Table 8:  
eMPloYMeNT STaTuS
eMPloYMeNT STaTuS %
Employed Full-time 17
Employed Part-time 4
Self-employed Full-time 5
Self-employed Part-time 2
Unemployed - Looking for Work 2
Government Training Scheme <1
Looking After Family/Home 2
Retired 56
Permanently Sick/Disabled 4
Temporarily Sick or Injured 8
Student <1
Other Reasons For Not Working 1
TOTAL 100
N = 34,708
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Table 7:  
MariTal STaTuS
MariTal STaTuS %
 Single 10
 Married 68
 Permanent Partnership 4
 Divorced 5
 Widowed 10
 Separated 3
TOTAL 100
N = 59,923
3%
10%
5%
4%
68%
10%
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Morbidities profile 
The number of CR patients with two or more co-morbidities (multi-morbid) 
is increasing across a range of different conditions (Table 9). Hypertension 
is the most common co-morbidity, affecting 63% of CR patients, followed 
by hypercholesterolaemia and diabetes. Previous NACR data analysis has 
shown that the extent of patient benefit from CR decreases as the number of 
morbidities increase (NACR 2013). Therefore, multi-morbid presentation should 
be an important consideration when carrying out baseline assessments and 
tailoring an intervention for patients. This is something the BACPR emphasises  
as best managed by a multidisciplinary team approach (BACPR 2017).
Table 9:  
MorbidiTieS Profile for Cr
MorbidiTY CaTeGorY WiTh 2 or More 
MorbidiTieS % 
Angina 23
Arthritis 18
Cancer 9
Diabetes 32
Rheumatism 3
Stroke 7
Osteoporosis 2
Hypertension 63
Chronic bronchitis (COPD) 5
Emphysema (COPD) 4
Asthma 10
Claudication 3
Chronic Back Problems 10
Anxiety 7
Depression 8
Family History 31
Erectile Dysfunction 3
Hypercholesterolaemia/Dislipidaemia 42
Other Comorbid Complaint 35
N= 43,399
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reasons for not taking part in Cr 
An essential step in supporting patients to attend CR is the realisation of its 
importance. The responsibility for this rests both with the service and the patient, 
which is why NACR asks clinicians to record ‘reasons for not taking part in CR’. 
With over 30,000 patients recording a response across all aspects of the patient 
journey we see that a ‘lack of interest’ remains as the main reason for not taking 
part in CR (Table 10). The number of responses informing the ‘reasons for not 
taking part’ analysis was distributed proportionally between males and females. 
As stated in previous NACR reports, some patients may genuinely not be 
interested in CR. There are three times as many patients suggesting a ‘lack of 
interest’ for core delivery of CR (phase III) as that seen for the early (phase I) part 
of the patient journey. Although a ‘lack of interest’ can be a genuine reason, CR 
service providers should try to offer an attractive range of CR options, preferably 
matched to patient preferences (Dalal et al 2007). A menu-based approach for 
the mode of delivery is a logical way to increase interest. 
Table 10:  
reaSoNS for NoT TaKiNG ParT iN Cr
reaSoN for NoT TaKiNG ParT earlY* 
%
iNTerMediaTe 
%
Core deliVerY** 
%
loNG TerM 
MaiNTeNaNCe %
Patient not interested/refused 14 25 39 54
Ongoing investigation 2 3 4 0
Physical incapacity 3 5 9 7
Returned to work <1 <1 3 4
Local exclusion criteria 5 8 3 4
Language barrier <1 <1 <1 <1
Holidaymaker <1 1 1 0 
Mental incapacity 9 1 1 <1
No transport <1 <1 1 <1
Died 4 5 2 <1
Not referred 5 1 <1 1
Too ill 3 3 4 1
Rehab not needed 5 5 3 5
Rehab not appropriate 9 8 8 2
Staff not available 7 <1 <1 0 
Rapid transfer to tertiary care 2 <1 <1 0 
Did not attend (DNA)/no contact 6 21 13 17
Transfer to another programme 2 3 2 <1
No service available <1 <1 <1 0 
Transfer for PCI/treatment 1 <1 <1 <1
Transfer to Hospital/Trust 15 1 1 0 
Other 5 5 5 4
Unknown 1 3 1 <1
TOTAL 100 100 100 100
N=8,144 N=5,783 N= 17,282 N=571
* Early (previously known as phase I) 
** UK Core Delivery (previously known as phase III) is equivalent phase II in Europe
briTiSh hearT fouNdaTioN
21 3 54 6NaCr Statistics by Country, health region and local Programme level
The NaTioNal audiT of CardiaC rehabiliTaTioN  
aNNuaL STATISTICAL REPORT 2017
32
reasons for not completing Cr 
The audit’s approach to reporting of CR completion and ‘reasons for not completing 
CR’ has changed this year with a stronger emphasis on ‘age and gender’ trends. Recent 
research and NACR audit findings have shown that older and younger patients vary in their 
likelihood to engage and attend CR depending on their gender (in press). We aim to apply 
the same analysis to CR completion. The percentage of patients that complete core CR is 
77%, which is a strong position for UK CR. Most well-resourced clinical trials have shown a 
dropout rate of 20-30% between pre- and post-CR assessment, which suggests that routine 
practice, as delivered in the UK, has good adherence. 
The data on the reason for patients not completing core CR (N = 8,670 patients) is collected 
for 80% of non-completers. This shows that a greater percentage of patients below 75 years 
did not attend (DNA) compared to those aged 75 years or above, and this was seen  
in both males and females. The two other dominant reasons for not completing were being 
‘too ill’ especially for the over 75s (>21%) and ‘returned to work’, which is a more frequent 
reason in patients aged below 75 years, especially for males (12%). Planned or emergency 
interventions or hospital re-admissions played a small part in non-completion of CR. 
Table 11:  
reaSoNS for NoT CoMPleTiNG Cr bY aGe aNd GeNder
GeNder reaSoNS for NoT CoMPleTiNG <75 YearS 
%
75+ YearS 
%
Male DNA Unknown Reason 43 23
Returned to Work 12 1
Left This Area 2 2
Achieved Aims <1 1
Planned/Emergency Intervention 2 2
Too Ill 9 22
Died 1 5
Other 24 41
Hospital Re-Admission 2 2
Unknown 6 3
Total 100 100
Female DNA Unknown Reason 38 22
Returned to Work 6 <1
Left This Area 2 2
Achieved Aims <1 <1
Planned/Emergency Intervention 2 1
Too Ill 15 21
Died 2 3
Other 29 42
Hospital Re-Admission 2 4
Unknown 6 4
TOTAL 100 100
<75 Male N = 4,973 Female N= 1,755   75+ Male N = 1,214 Female N= 728
Patients with reason for not completing recorded.
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Mode of delivery in modern uK Cr 
There is strong evidence that CR can be delivered successfully through different modes 
such as centre/group or individually as part of a facilitated home-based programme 
(Anderson et al 2017, Dalal et al 2010). Web-based options are also being investigated 
at this present time through the WREN trial. Based on the need for a tailored approach 
to CR and the evidence that patient preference is important, NACR has taken a fresh 
approach to understanding the importance of the mode of CR delivery in clinical practice.
The new approach splits mode of delivery by gender and age (Table 12), which are two 
factors known to influence patient choice. The table also separates out HF patients as this 
diagnosis is thought to impact on the type of service offered by providers and may help 
inform patient preference.
Group-based CR dominates the mode of delivery across age, gender and diagnosis (range 
64% to 85%) with a slightly higher proportion of males on average (78%) carrying out 
group-based compared to females (75%). Home-based CR (including the Heart Manual) is 
higher in the conventional CR patient group with slightly higher use in females compared 
to the HF group. This is hardly surprising as there is no valid HF-specific home-based 
programme with an evidence base. The REACH-HF trial (Taylor et al 2015) is testing  
the hypothesis that home-based CR is effective in patients with HF. Web-based CR is also 
slowly emerging as an option in the conventional CR patient group. 
Table 12:  
Mode of deliVerY SPliT bY aGe, GeNder aNd diaGNoSiS/TreaTMeNT GrouPS
all diaGNoSiS/TreaTMeNT GrouPS hearT failure
GeNder Mode of deliVerY <75 YearS 
%
75+ YearS 
%
<75 YearS 
%
75+ YearS 
%
Male Group-based 82 72 84 74
Home-based 8 12 4 6
Web-based <1 <1 <1 <1
Home Visits 6 11 5 14
Telephone 15 19 15 17
Other Mode 30 30 39 42
Female Group-based 79 64 85 73
Home-based 9 15 3 7
Web-based <1 <1 <1 <1
Home Visits 8 14 4 18
Telephone 17 23 12 13
Other Mode 31 32 36 39
Total Group-based 81 70 85 74
Home-based 8 13 4 6
Web-based <1 <1 <1 <1
Home Visits 7 12 5 15
Telephone 16 20 14 16
Other Mode 30 31 38 41
N=56,396 patients with a mode of delivery completed
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Timely CR, delivered soon after discharge from acute services or as part of a step change in clinical 
treatment for CVD, is a key recommendation of SIGN (2017), and NICE CG172 and forms one of the 
minimum standards of the BACPR. Table 13 shows that waiting times vary substantially within each 
country and between each country. 
In England the national wait time average (median) is 28 days for MI/PCI (MI and/or PCI) and 41 
days for CABG patients. The national averages for Northern Ireland were 30 and 42 days for MI/PCI 
and CABG, respectively. Wales has the lowest wait times at 23 days for MI/PCI and 38 days for CABG 
patients. A recent BMJ clinical update noted that 90% of patients admitted with STEMI (ST segment 
elevation myocardial infarction) have a primary PCI and are discharged within three days allowing 
little time for referral to CR from hospital. It is hoped that a combination of primary and community 
care will alleviate this problem through early engagement (Dalal F et al 2017). 
is Cr delivered early enough to meet  
national guidance? 
In 2017, the BACPR released its new standards and core components (BACPR 2017).  
The six standards for cardiovascular prevention and rehabilitation are:
1.  The delivery of six core components by a qualified and competent multidisciplinary team,  
led by a clinical coordinator.
2.  Prompt identification, referral and recruitment of eligible patient populations.
3.  Early initial assessment of individual patient needs which informs the agreed personalised goals 
that are reviewed regularly.
4.  Early provision of a structured cardiovascular prevention and rehabilitation programme (CPRP), 
with a defined pathway of care, which meets the individual’s goals and is aligned with patient 
preference and choice.
5.  Upon programme completion, a final assessment of individual patient needs and 
demonstration of sustainable health outcomes.
6.  Registration and submission of data to NACR and participation in the National Certification 
Programme for Cardiovascular Rehabilitation (NCP_CR).
Results from BHF led research, using NACR data, has shown that timely CR is associated with 
greater patient benefit, in terms of physical and psychosocial outcomes, compared to CR offered 
late (Fell et al 2016, Sumner et al 2017). The BACPR (2017) NICE service guidance (CG172, CG108) 
and SIGN (2017) recommend that CR programmes should be offered early, and underpinned 
by assessment prior to, and on completion of, CR. The duration and frequency of CR, based 
on NICE guidance (NICE CG172) and Cochrane Review (Anderson et al 2016) should ideally be 
12 weeks (or no less than eight weeks) at a frequency of twice per week. The CR team should be 
multidisciplinary with professionals that possess the skills and competences to support patients 
in achieving the desired health behaviour change and to enable these same skills, in patients and 
their carers, as part of a long term self-management approach (BACPR 2017).
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Table 13:  
TiMe (daYS) froM PoST diSCharGe referral To STarT of Cr bY CouNTrY, healTh reGioN aNd diaGNoSiS/TreaTMeNT
CouNTrY healTh reGioN Mi aNd/or PCi CabG
England $. 36- 57-
EM 32- 41+
E o E 24+ 42-
(.-4$ 26+ 39+
L 30- 42-
SEC 29- 38+
SW 34- 41+
TV 28+ 50-
W 25+ 43-
WM 29- 36+
:5) 19+ 35+
Total 28 41
Northern Ireland BHSCT 27+ 40+
NHSCT 37- 48-
SEHSCT 28+ 38+
SHSCT 47- 78-
Total 30 42
Wales ABM 42- 63-
AB 35- 41-
BC* 6+ 4+
$7 36- 44-
CT 19+ 25+
HD 78- 96-
Total 23 38
Other Other 42 58
TOTAL 28 41
 
N=26,332 - or + nation specific referral time criteria: - = not met, + = met 
* figures confirmed by clinical team lead 
NE and WHSCT have been removed due to insufficient NACR data
21 3 54 6analysis based on National Minimum Standards
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Variation in the timing of CR by country is not surprising as the health delivery infrastructure is 
commissioned, funded and incentivised differently. Our research has shown that the solutions to poor 
CR engagement are as much to do with service level factors in each country as they are with patient 
choice (Al Quait, Doherty 2017). What this means for the national audit is that UK national averages 
are potentially unreasonable benchmarks and that nation-specific averages are preferable as they 
are more likely to reflect a norm for high and low service performance relevant to the health delivery 
system for each country. 
From 2017 onwards NACR will include more country-specific reporting to enable in-country analysis 
and evaluation of how their own programmes are performing. All three nations have different 
approaches to service-level funding and commissioning with additional variation in key performance 
indicators. The ability to address service-level quality and inequalities in delivery and patient 
outcomes is dependent on the infrastructure, resources and financial models supporting CR services. 
In-country reporting will also enable each nation to more clearly identify average trends and high/low 
performance within their service delivery infrastructure which can be used to inform country-specific 
benchmarking and shared learning. To this end, NACR now uses nation-specific averages for wait time, 
duration and percentage assessment in this report. 
Although Scotland is not presently entering data into NACR we are pursuing a new data governance 
application which, if successful, will allow a pilot study of data sharing between Lothian NHS CR 
services and NHS Digital in 2018.
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There is considerable variation at local programme level in all three nations. However, one common 
feature is that for all but 15 programmes, patients with MI/PCI wait for shorter periods than those 
with CABG (Figure 2 a-c.). For England (Figure 2a), around half of all MI/PCI and CABG patients 
start CR within a reasonable time frame with some indicating that patients are started within just 
a few days. There are around ten programmes in England with shorter CR wait times (<8 days 
and as low as just one day) for MI/PCI and CABG patients, which either reflects very early CR or 
a misunderstanding about what constitutes the start of CR. The situation for Wales (Figure 2c) is 
similar to that of England whereas the trend in Northern Ireland is different (Figure 2b). In Northern 
Ireland none of the programmes offer CR earlier than 27 days for MI/PCI and 38 days for patients 
following CABG. Their wait times are within guideline recommended periods which reinforces our 
concern that in England and Wales some programmes may have a different understanding of what 
constitutes starting CR. 
There is more work for CR providers and the NACR team to do in clarifying what is understood by 
starting CR such as: when a first assessment takes place, whether goal setting has happened for  
an individual patient and when does an actual CR intervention, based on assessment, commence. 
As the health landscape changes, innovation in service delivery is important and so is the need  
to capture such changes through audit. In order to support innovations in service delivery  
the BHF Alliance offers programmes the ability to share practice at www.bhf.org.uk/alliance.
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Proportion of patients starting Cr with  
a record of pre- and post-Cr assessment 
There has been a positive shift this year in the number of patients starting CR with a 
comprehensive assessment, which is encouraging news as assessment is a key recommendation 
of SIGN 2017 and NICE CG172 and forms one of the minimum standards of the BACPR. This year, 
83% of patients that started CR had a baseline assessment which is a four percentage point 
improvement on last year (Table 14). Building on last year’s report, which set a recommendation 
that more patients should be assessed at the end of CR, we can share more success with 62% of 
patients starting CR now having a follow-up assessment which is a six percentage point increase 
on last year (2,851 more patients). Slight variation exists between the nations with Northern 
Ireland showing a greater proportion of assessments at baseline whereas England has the higher 
number of assessments following CR.
More CR teams should capitalise on this trend and strive to assess all patients that complete 
CR. In this year’s annual report we see 77% of patients completing rehabilitation; based on the 
BACPR minimum standards all of these should have had an assessment (BACPR 2017). However, 
15% of patients completed CR without an assessment (7,128 patients): this means programmes 
cannot be assessed for improving outcomes. A further implication for those patients completing 
CR without a follow-up assessment is that they will not have had quantifiable notification of their 
progress which we know is important as part of successful health behaviour change. This also 
has implications for a tailored long-term management plan that would normally build on the 
progress of their initial CR goals.
Table 14:  
PerCeNTaGe STarTiNG Cr WiTh a reCord of Pre- aNd PoST-aSSeSSMeNT bY healTh reGioN
CouNTrY healTh reGioN STarTiNG 
rehabiliTaTioN (N)
% WiTh Pre 
(aSSeSSMeNT 1)
% WiTh PoST 
(aSSeSSMeNT 2)
England $. 2,845 83 62
EM 3,733 86 64
E o E 4,067 83 65
(.-4$ 5,872 73 56
L 4,970 90 62
SEC 4,304 86 65
SW 4,303 93 60
TV 1,732 80 69
W 2,366 89 71
WM 2,983 63 53
:5) 3,407 90 73
Total 40,582 83 63
Northern Ireland BHSCT 573 98 62
NHSCT 593 90 61
SEHSCT 610 88 67
SHSCT 327 83 39
WHSCT 114 74 68
Total 2,217 90 60
Wales ABM 684 94 81
AB 860 95 64
BC 1,867 60 38
$7 299 92 73
CT 421 78 54
HD 363 82 52
Total 4,494 78 54
Other Other 107 99 89
TOTAL 47,520 83 62
England N=40,582, Northern Ireland N=2,217, Wales N=4,494, Total N=47,520 (includes Other)
NE has been removed due to insufficient NACR data
briTiSh hearT fouNdaTioN
21 3 54 6analysis based on National Minimum Standards
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Successful health behaviour change programmes involving exercise training, physical activity, 
risk factor management and psychosocial wellbeing interventions all require time to achieve the 
desired goals set by patients. The most recent CR effectiveness Cochrane Review (Anderson et al 
2016) of 63 clinical trials found that the median duration was six months (range one to 48 months). 
In routine clinical practice, where funding is more likely to be a determinant of CR duration, the 
range is three months in the USA, five months in Canada and recommended at a minimum of 12 
weeks across Europe. In all these countries the preferred frequency is two to three formal sessions 
per week (Suaya et al 2007, Vanhees et al 2012). What is clear from this is that duration, at or above 
12 weeks, is common to successful CR programmes which in essence give patients sufficient time 
to make the required lifestyle changes.
The median duration for CR in this year’s report was nine weeks (Table 15) which is one week above 
the BACPR recommended minimum standard of eight weeks (BACPR 2017).
The percentage of patients who received at least eight weeks of CR was 71% in Wales (range 49% 
to 85%), 59% in England (range 35% to 80%) and 46% in Northern Ireland (range 12% to 75%) 
(Table 15, Figure 3 a-c). In-country variation for the duration of CR is high with some locations 
running very short programmes and therefore having potentially too little time to support health 
behaviour change.
The interaction between duration (length) and CR dose (frequency of sessions) is not yet 
understood, and ongoing analysis of programme data aims to produce a more meaningful 
interpretation of this relationship and its impact on patient outcomes.
is the duration of Cr meeting national guidance? 
Table 15:  
MediaN leNGTh of Cr (daYS)
CouNTrY healTh reGioN ToTal ProGraMMe 
duraTioN (daYS)
% MeeTiNG or GreaTer ThaN 
 56 daYS (baCPr 2017)
England $. 63 58
EM 49 35
E o E 70 68
(.-4$ 63 57
L 61 53
SEC 57 50
SW 63 54
TV 63 58
W 63 57
WM 80 80
:5) 84 74
Total 63 59
Northern Ireland BHSCT 80 74
NHSCT 52 39
SEHSCT 70 75
SHSCT 42 12
WHSCT 49 28
Total 59 46
Wales ABM 63 62
AB 77 81
BC 113 79
$7 56 49
CT 100 85
HD 82 72
Total 77 71
Other Other 38 11
TOTAL 63 58
N= 36,250 
NE has been removed due to insufficient NACR data
ParT four: aNalYSiS baSed oN NaTioNal 
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Last year the NACR Statistical Report introduced service-level metrics to assess the overall 
performance against six key indicators and published a peer-reviewed version of this approach  
and analysis (Doherty et al 2017). This year we have expanded further to report these metrics for 
each nation (Table 16). Currently there are two agreed minimum standards: (1) CR offered to all  
six priority groups and (2) duration of CR of at least eight weeks (56 days).  
 
The other four standards (which are pre-CR assessment 1, post-CR assessment 2, and wait time 
to CR for CABG and MI/PCI patients) are based on the national averages, year-on-year, for each 
country. We have utilised country-specific averages and compared programmes within countries 
for meeting their national averages (Tables 16). As CR service quality improves in respect of these 
four standards, evidenced through increased national averages, the BACPR and NACR will agree  
a minimum standard for assessment and timeliness of CR. For this section, we have reported  
the extent by which programmes meet the six standards for each Health Region and country 
 in Figure 4a-c. 
 
The NACR approach to nation-specific analysis of programme quality allows national leads and  
CR programmes in each country to see where their strengths and weaknesses reside and use this 
to help inform their strategy for improvement. This approach reflects the context, infrastructure 
and resources for each country, which will help set realistic expectations. In this year’s analysis,  
it is clear that a fully inclusive approach to all patient priority groups, as seen in Wales, and shorter 
duration of CR, as seen in Northern Ireland, were influential in defining high and low performance 
category allocations.
Future NACR reports will include an evaluation of the frequency of CR sessions. Our recent analysis 
revealed considerable variation in how a ‘CR session’ is carried out or recorded in NACR. For 
instance, we know that many programmes run supervised exercise training and education sessions 
back-to-back (same period of time) yet record this as one session on NACR. To help CR programmes 
understand what constitutes an auditable ‘CR session’ the BACPR and NACR will produce a joint 
position statement by Spring 2018. 
Summary of Cr programmes against national 
averages for service delivery performance indicators 
ParT four: aNalYSiS baSed oN NaTioNal 
MiNiMuM STaNdardS
Table 16: 
PerCeNTaGe of ProGraMMeS aChieViNG Cr PerforMaNCe iNdiCaTorS
Cr ProGraMMeS/SiTeS MeeTiNG STaNdardS
KeY PerforMaNCe iNdiCaTorS STaNdard eNGlaNd % NorTherN irelaNd % WaleS %
Agreed minimum 
standards
Receiving All  
Priority Groups
Each group >0 85 75 100
Duration 56 (days) 71 50 80
Standards based  
on 2015-16  
national averages
% with Pre 
(Assessment 1)
England 83%
 Northern Ireland 90% 
Wales 78%
51 67 65
% with Post 
(Assessment 2)
England 63% 
Northern Ireland 60% 
Wales 54%
47 42 59
Referral to Start 
MI/PCI
England 28%
 Northern Ireland 30%
Wales 23%
37 42 29
Referral to Start 
CABG
England 41%
Northern Ireland 42%
 Wales 38%
39 58 41
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briTiSh hearT fouNdaTioN
The aNalYSiS of NaTioNal MiNiMuM STaNdardS for healTh reGioNS iN eNGlaNd
Figure 4a shows an overall trend towards most regions (ten out of 12) meeting three to six 
standards (light grey and beige). Between 8% to 67% of CR programmes, in seven Health Regions,  
either do not meet any of the standards or do not submit data (red bars).  
 
The aNalYSiS of NaTioNal MiNiMuM STaNdardS for Cr for healTh  
aNd SoCial Care TruSTS iN NorTherN irelaNd
Of the five Health and Social Care Trusts all programmes in one Trust met most of the standards 
(beige bar) whereas in one other Trust 50% of programmes failed to meet any of the standards  
or meet just one to two of the standards (Figure 4b). The situation for the three other Trusts  
was orientated to meeting one to six of the standards.  
 
The aNalYSiS of NaTioNal MiNiMuM STaNdardS for Cr for healTh boardS iN WaleS
Of the seven Health Boards three had significant positive trends in meeting five to six standards  
(beige bars), five met three to four standards (light grey bars) and two had a range to 50% to 100%  
(red bars) not meeting any of the standards (Figure 4c). 
21 3 54 6
analysis based on National 
Minimum Standards
fiGure 4 a-c: PerCeNTaGe of ProGraMMeS aChieViNG PerforMaNCe iNdiCaTor SPliT bY healTh reGioN
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The BACPR 2017 recommends that CR is delivered by a multidisciplinary team (MDT) 
of skilled and experienced staff who aim to support a multi-morbid patient population 
to achieve optimal outcomes from CR (Table 9). The overall range of professionals 
supporting CR is comprehensive, however, the variation across different countries  
is considerable (Table 17). 
There are no obvious shifts from previous years, however, there was a significant 
improvement of 17 percentage points in the secretarial support on last year, which is 
encouraging as this is often seen as one of the major staffing deficits of the core CR team. 
This change was most evident in Wales with a 39 percentage point increase. The only 
significant reduction in staffing was in the occupational therapist role which fell by nine 
percentage points. 
 
A more detailed breakdown of CR staffing by programme/site is available on  
the NACR webpage: www.cardiacrehabilitation.org.uk/current-annual-report.htm 
 
NACR this year has reported the level of MDTs present at local programmes. The chart 
shows the proportion of different members of staff per programme nationally. The BACPR 
state that a programme, to achieve the variety of patient aims, needs to comprise of  
at least three different disciplines. There are 93% of programmes with three or more  
staff disciplines, which is a positive situation for the UK. However, 9% of programmes fail  
to meet this essential core component.
is Cr delivered by a multidisciplinary team  
as recommended by national guidance?
Table 17:  
STaffiNG Profile for Cr ProGraMMeS aCroSS The uK
eNGlaNd NorTherN irelaNd WaleS uK ToTal
CaTeGorY N= 200 N= 11 N= 20 N= 234
N % N % N % N %
Nurse 194 97 10 91 20 100 227 97
Physiotherapist 134 67 11 100 18 90 165 71
Dietician 94 47 7 64 11 55 114 49
Psychologist 29 15 6 55 2 10 37 16
Social Worker 0 0 0 0 0 0 0 0
Counsellor 19 10 0 0 2 10 21 9
Doctor 16 8 4 36 0 0 21 9
Health Care Assistant 33 17 0 0 1 5 34 15
Secretary 153 77 8 73 19 95 181 77
Administrator 15 8 0 0 0 0 15 6
Exercise Specialist 114 57 1 9 9 45 124 53
Occupational Therapist 47 24 1 9 12 60 61 26
Pharmacist 72 36 10 91 11 55 95 41
Physiotherapy Assistant 55 28 1 9 5 25 62 26
45
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breakdown of the multidisciplinary team
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ParT fiVe: 
eValuaTioN of PaTieNT  
ouTCoMeS folloWiNG Cr  
bY CouNTrY, healTh reGioN  
aNd loCal ProGraMMe
The raNGe of iMProVeMeNTS  
iN PhYSiCal aCTiViTY leVelS  
iN PaTieNTS folloWiNG  
Cr iN 2015-16. 
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The total number of patients entering CR as non-smokers is on average 93.6%, which is similar to last year  
(range 85.9% to 98.8%) (Table 18, Figure 5a-c) with proportions comparable in each of the three nations at baseline.
Supporting patients to stop smoking remains a top priority and there are some programmes doing rather well  
at it with a 12.5 percentage point reduction in the number of patients smoking following CR while other programmes  
are not demonstrating any change or even worse, some are seeing an increase in the number of patients identified  
as smokers post-CR. The mean change for the UK was 1.4 percentage points with a range of -0.2 to 2.9 percentage 
points across England, Northern Ireland and Wales. 
 
The CR contribution to smoking cessation at a national level remains positive overall; however, the range of change 
was -0.5 to 4.8 percentage points for England, 0.0 to 12.5 percentage points for Northern Ireland and -1.3 to 2.1 
percentage points for Wales (Table 18).
The situation at a local level (Figure 5 a-c) is more complex and varied with 15 programmes showing a negative 
impact in England (Figure 5a), one in Northern Ireland (Figure 5b) and three negative values in Wales (Figure 5c). 
Further clarification around the varying smoking states need to be investigated as some of the negative change  
could be explained by patients reverting back to smoking. The scale of the challenge, in terms of smoking status  
at the point patients enter CR, is very different from programme to programme.
Based on the success of last year’s local reporting approach we have continued this and extended  
it to individual graphical reports for each country. The approach shows baseline values per programme  
in one colour with the percentage change following CR as a different colour using the same graphical bar.
analysis of Cr contribution to smoking cessation 
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Table 18:  
PerCeNTaGe of NoN-SMoKerS
CouNTrY healTh reGioN Pre % PoST % PoiNT ChaNGe %
England $. 93.6 94.5 0.8
EM 93.5 93.8 0.4
E o E 95.9 96.0 0.1
(.-4$ 94.9 95.6 0.7
L 93.7 95.2 1.5
SEC 95.8 96.3 0.6
SW 94.6 96.6 2.0
TV 96.0 95.5 -0.5
W 94.5 96.4 1.9
WM 91.6 96.0 4.4
:5) 85.9 90.7 4.8
Total 93.5 95.0 1.5
Northern Ireland BHSCT 92.3 92.6 0.2
NHSCT 88.1 97.2 9.1
SEHSCT 94.7 94.7 0.0
SHSCT 98.8 100.0 1.2
WHSCT 87.5 100.0 12.5
Total 92.3 95.2 2.9
Wales ABM 96.2 95.3 -0.9
AB 94.0 94.0 0.0
BC 96.1 94.8 -1.3
$7 96.8 96.8 0.0
CT 88.1 88.1 0.0
HD 95.8 97.9 2.1
Total 95.4 95.2 -0.2
Other Other 97.7 94.3 -3.4
TOTAL 93.6 95.0 1.4
 
England N=19,167, Northern Ireland N=1,137, Wales N=1,533, Total N=21,924 (includes Other)
NE and PT are not shown in any outcomes tables as there is insufficient data. 
See Table 3 for abbreviations. 
In all of the following tables the total percentage may be slightly above 100% due to rounding.
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fiGure 5 a-c: PerCeNTaGe ChaNGe iN NoN-SMoKerS PoST-Cr bY ProGraMMe
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Although physical fitness improvement as measured by fitness testing (e.g. shuttle walk test) is an expected 
outcome from CR, it is not inevitable that this leads to an increase in physical activity status, which is 
a measurement of how much physical activity (e.g. walking, light housework) an individual does in an 
average week. The Chief Medical Officers (CMOs) for all nations of the UK recommend 150 minutes per 
week of moderate intensity physical activity as part of a public health initiative. This requirement has been 
adopted as a basic minimum requirement for the BACPR (2017) and SIGN (2017). 
In this audit period, 41.6% of patients at baseline CR met the recommendation of 150 minutes which 
increased to 70% following CR (Table 19). The average percentage point change for each nation was 27.5, 
41.3 and 27.0 for England, Northern Ireland and Wales respectively (Table 19) all of which indicates a 
positive outcome following CR (Figure 6 a-c). The extent of change in Northern Ireland was strongly positive 
(>41%) with 13% greater change compared to other nations. 
The profile of physical activity status at the point patients enter CR is very different at a local level.  
For instance, the baseline activity state ranged from 8% of patients meeting the 150 minute 
recommendation in one programme to 90% in another. This makes simple comparisons of percentage 
point change at a programme level difficult to judge, as the potential for change is greater in those 
programmes with low baseline activity levels. On the other hand, these patients may have habituated 
being less active which could mean they are less likely to change. The same could also be applied to those 
less active patients in the high baseline groups as they too may be less likely to change. 
This year we have again reported physical activity status at a named programme level. This is an important 
lifestyle risk factor and a UK wide recommendation. The audit is keen to receive feedback on this recent 
addition to reporting as we move forward with this, and HADS, at a named local programme level. 
The report is available from http://www.cardiacrehabilitation.org.uk/current-annual-report.htm
analysis of Cr contribution to physical activity status
Table 19:  
ChaNGe iN PhYSiCal aCTiViTY STaTuS (150 MiNuTeS Per WeeK) folloWiNG Cr bY healTh reGioN
CouNTrY healTh reGioN Pre % PoST % PoiNT ChaNGe %
England $. 36.2 66.9 30.6
EM 42.4 58.5 16.1
E o E 42.3 73.6 31.3
(.-4$ 45.3 72.4 27.1
L 39.8 69.8 30.0
SEC 40.8 71.4 30.6
SW 52.3 73.1 20.7
TV 43.7 75.0 31.3
W 43.5 75.9 32.4
WM 41.1 80.8 39.7
:5) 38.4 60.5 22.1
Total 42.4 69.8 27.5
Northern Ireland BHSCT 32.7 75.1 42.4
NHSCT 38.6 73.7 35.1
SEHSCT 20.3 61.3 41.0
SHSCT 40.0 86.7 46.7
Total 28.6 69.9 41.3
Wales ABM 39.1 66.5 27.4
AB 37.8 64.5 26.7
BC 29.4 62.2 32.8
$7 44.4 72.8 28.4
CT 31.4 66.7 35.3
HD 43.3 58.3 15.0
Total 38.9 65.9 27.0
Other Other 53.6 94.0 40.5
TOTAL 41.6 69.7 28.1
England N=14,369, Northern Ireland N=675, Wales N=1,179, Total N=15,830 (includes Other)
WHSCT has been removed due to insufficient NACR data
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Around a third of the CR population begin rehabilitation with a BMI greater than 30. A key aim  
of CR and a goal for most patients is to bring BMI below a value of <30 (BACPR 2017). 
The average change seen across countries is low, with an increase of only 0.3 to 0.8 percentage 
points in patients in patients with BMI <30. This highlights the difficulty in addressing this risk 
factor (Table 20 and Figure 7 a-c.) Regional and local programme variation exists with a range 
of change of -1.2 to 7.6 percentage points which suggests that some programmes may be 
doing slightly better than others, and could highlight an opportunity for sharing best practice. 
However, the ability for a programme to make substantial change in patients’ BMI may also  
be hindered by their own success in smoking cessation. Evidence suggests that patients trying 
to quit smoking are more likely to put on between three and five kilograms in the first three 
months to a year (Aubin et al 2012). This substantial effect may inhibit reporting of some 
successful weight loss programmes but, at a national level, patients losing weight and moving 
to BMI <30 is evidence that CR is positively associated with weight management. With regards 
to smoking and weight interactions, NACR data analysis concludes that the extent of weight 
gain associated with smoking cessation in patients attending CR is much less than previous 
studies suggest. 
analysis of Cr contribution to body Mass index (bMi) 
Table 20:  
PerCeNTaGe of PaTieNTS WiTh bMi <30 Pre- aNd PoST-Cr
CouNTrY healTh reGioN Pre  % PoST % PoiNT ChaNGe % 
England $. 67.2 66.8 -0.4
EM 65.1 64.6 -0.4
E o E 68.8 69.3 0.5
(.-4$ 70.1 71.4 1.3
L 71.5 71.1 -0.4
SEC 73.9 75.6 1.7
SW 72.3 74.9 2.6
TV 66.8 68.3 1.4
W 72.5 74.3 1.8
WM 67.1 67.2 0.1
:5) 67.8 69.5 1.8
Total 69.8 70.7 0.8
Northern Ireland BHSCT 61.7 61.9 0.2
NHSCT 64.0 64.8 0.8
SEHSCT 68.9 70.3 1.5
SHSCT 70.4 70.4 0.0
Total 64.9 65.6 0.7
Wales ABM 67.0 66.5 -0.4
AB 60.1 61.5 1.4
BC 67.8 70.3 2.5
$7 66.2 65.5 -0.6
CT 68.0 68.0 0.0
HD 70.6 71.3 0.7
Total 65.5 65.8 0.3
Other Other 74.4 73.3 -1.2
TOTAL 69.3 70.1 0.8
 
England N=17,058, Northern Ireland N=1,003, Wales N=1,439, Total N=19,593 (includes Other)
WHSCT has been removed due to insufficient NACR data
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At baseline around 72.5% of patients present within the normal HADS anxiety category,  
with 27.6% residing in the clinical and borderline categories at the point they enter CR (Table 
21). Variation in the burden of anxiety is evident across countries and Health Regions, with 
averages of 14.7%, 13.1% and 11.8% for clinical levels of anxiety in Wales, Northern Ireland 
and England, respectively. Change in patient status from clinically anxious to borderline and 
normal categories is well distributed and for the most part positive across Health Regions 
(Table 21 and 22). Overall there was a 6.3 percentage point shift from clinically/borderline 
anxious to the normal anxiety category (Table 22). National and regional values suggest 
that most patients benefit from CR, however, there is large variation in the extent of this 
improvement at a local level from -9.0% to 28.7% (Figure 8 a-c). Around 65% of programmes 
met or exceeded the 6.3 percentage point national average change in anxiety which is 
encouraging, however, further work is required to ensure that more patients are supported  
to achieve close to the average change following CR.
analysis of Cr contribution to hadS anxiety levels 
Table 21:  
PerCeNTaGe of PaTieNTS bY hadS aNXieTY CaTeGorieS Pre- aNd PoST-Cr
Pre PoST
CouNTrY healTh reGioN NorMal % borderliNe % CliNiCallY 
aNXiouS %
NorMal % borderliNe % CliNiCallY 
aNXiouS %
England $. 72.6 15.0 12.4 78.1 12.4 9.5
EM 71.5 15.5 13.0 75.3 15.0 9.7
E o E 73.2 15.1 11.8 81.0 11.9 7.1
(.-4$ 70.4 17.1 12.5 77.5 13.4 9.0
L 69.3 16.7 14.1 75.0 14.9 10.1
SEC 75.2 14.0 10.8 81.1 11.1 7.9
SW 74.9 16.7 8.4 84.3 11.6 4.1
TV 74.7 15.1 10.2 83.4 10.2 6.3
W 76.0 15.9 8.1 82.4 11.7 5.9
WM 74.3 13.7 12.0 79.0 13.9 7.1
:5) 71.3 16.0 12.8 79.3 12.3 8.3
Total 72.6 15.6 11.8 79.0 12.8 8.2
Northern Ireland BHSCT 65.4 17.1 17.4 74.8 13.8 11.4
NHSCT 78.3 11.5 10.2 82.3 11.5 6.2
SEHSCT 81.0 8.5 10.4 80.6 12.3 7.1
Total 74.2 12.7 13.1 78.0 13.5 8.5
Wales ABM 69.0 16.6 14.4 76.6 14.1 9.2
AB 65.8 15.4 18.8 75.7 12.9 11.4
BC 72.3 13.9 13.9 79.2 13.9 6.9
$7 70.7 16.3 13.0 75.9 15.2 8.9
HD 72.8 16.2 11.0 72.3 17.8 9.9
Total 69.4 15.9 14.7 75.8 14.6 9.6
Other Other 83.5 9.4 7.1 85.9 8.2 5.9
TOTAL 72.5 15.5 12.1 78.7 12.9 8.3
England N=14,183, Northern Ireland N=810, Wales N=1,255, Total N=16,356 (includes Other)
4)4$58)4$5$5IBTCFFOSFNPWFEEVFUPJOTVöDJFOU/"$3EBUB
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Table 22:  
PerCeNTaGe PoiNT ChaNGe iN hadS aNXieTY CaTeGorieS folloWiNG Cr
PoiNT ChaNGe
CouNTrY healTh reGioN NorMal % borderliNe % CliNiCallY aNXiouS %
England $. 5.5 -2.5 -2.9
EM 3.7 -0.5 -3.2
E o E 7.8 -3.2 -4.6
(.-4$ 7.1 -3.6 -3.5
L 5.7 -1.7 -4.0
SEC 5.9 -3.0 -2.9
SW 9.4 -5.2 -4.3
TV 8.8 -4.9 -3.9
W 6.4 -4.2 -2.1
WM 4.7 0.2 -4.9
:5) 8.1 -3.6 -4.4
Total 6.4 -2.8 -3.6
Northern Ireland BHSCT 9.4 -3.4 -6.0
NHSCT 4.0 0.0 -4.0
SEHSCT -0.5 3.8 -3.3
Total 3.8 0.7 -4.6
Wales ABM 7.6 -2.4 -5.2
AB 9.8 -2.5 -7.4
BC 6.9 0.0 -6.9
$7 5.2 -1.1 -4.1
HD -0.5 1.6 -1.0
Total 6.4 -1.4 -5.0
Other Other 2.4 -1.2 -1.2
TOTAL 6.3 -2.5 -3.7
England N=14,183, Northern Ireland N=810, Wales N=1,255, Total N=16,356 (includes other)
4)4$58)4$5$5IBTCFFOSFNPWFEEVFUPJOTVöDJFOU/"$3EBUB
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Around 19% of patients present within the clinical and borderline categories of depression at the point 
they enter CR (Table 23). Variation in the burden of depression is evident across countries and Health 
Regions, with averages of 6.6%, 6.8% and 9.6% for clinical levels of depression in England, Northern 
Ireland and Wales respectively. Changes in patient status from clinically depressed to borderline and 
normal categories are evenly distributed and mostly positive across all Health Regions (Table 23 and 24). 
There was a decrease in the percentage of patients in the clinically depressed and borderline groups, 
2.4 and 3.8 percentage points, respectively, across all countries, and a 6.2 percentage point positive 
movement to the normal group (Table 24). Performance at national and regional level suggests that 
most patients benefit from reduced levels of depression after CR. However, there is large variation in the 
extent of this improvement at a local level from -8.1 to 24.3 percentage points (Figure 9 a-c). At a regional 
and local level 60% of programmes met or exceeded the 6.2 percentage point national average change 
in depression which is encouraging, however further work is required to ensure that more patients are 
supported to achieve close to the nation-specific average change following CR.
This year, along with the local reporting of physical activity status, we are publishing the HADS 
categories for pre-CR, post-CR and the change in each category at a named local programme level.  
This will be produced for both anxiety and depression which are indicators for psychosocial health, a key 
aim for programmes to address with patients. This is the direction the audit is continuing to adopt across 
different patient outcome measures and we appreciate feedback on its methodology and impact. 
The report is available from: http://www.cardiacrehabilitation.org.uk/current-annual-report.htm
analysis of Cr contribution to hadS depression levels
Table 23:  
PerCeNTaGe of PaTieNTS bY hadS dePreSSioN CaTeGorieS Pre- aNd PoST-Cr
Pre PoST
CouNTrY healTh reGioN NorMal % borderliNe % CliNiCallY 
dePreSSed %
NorMal % borderliNe % CliNiCallY 
dePreSSed %
England $. 79.7 12.1 8.2 86.8 8.5 4.7
EM 81.8 11.2 7.0 85.4 9.4 5.2
E o E 84.5 10.3 5.2 90.9 5.3 3.8
(.-4$ 80.3 11.8 7.8 87.0 8.2 4.8
L 77.1 14.2 8.8 84.0 10.1 5.9
SEC 82.1 11.5 6.4 89.0 6.7 4.3
SW 85.6 10.9 3.4 92.1 4.7 3.2
TV 79.6 14.4 5.9 88.5 7.7 3.8
W 87.1 9.7 3.2 92.1 6.5 1.4
WM 85.9 8.8 5.3 87.4 8.5 4.1
:5) 79.2 13.7 7.1 86.6 8.3 5.1
Total 81.6 11.8 6.6 87.8 7.8 4.4
Northern Ireland BHSCT 79.5 12.1 8.4 87.9 7.4 4.7
NHSCT 86.7 8.0 5.3 88.9 8.8 2.2
SEHSCT 85.8 9.0 5.2 89.1 7.6 3.3
SHSCT 84.0 6.7 9.3 88.0 5.3 6.7
Total 83.6 9.6 6.8 88.5 7.7 3.8
Wales ABM 75.5 15.0 9.5 84.2 10.9 4.9
AB 75.7 12.6 11.7 84.0 9.5 6.5
BC 82.2 7.9 9.9 85.1 11.9 3.0
$7 83.0 9.2 7.7 88.6 7.7 3.7
HD 75.3 15.8 8.9 77.4 13.2 9.5
Total 77.7 12.7 9.6 84.1 10.3 5.6
Other Other 89.4 8.2 2.4 96.5 1.2 2.4
TOTAL 81.4 11.8 6.8 87.6 8.0 4.4
England N=14,165, Northern Ireland N=810, Wales N=1,254, Total N=16,337 (includes Other)
8)4$5$5IBTCFFOSFNPWFEEVFUPJOTVöDJFOU/"$3EBUB
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Table 24:  
PerCeNTaGe PoiNT ChaNGe iN hadS dePreSSioN folloWiNG Cr
PoST
CouNTrY healTh reGioN NorMal % borderliNe % CliNiCallY dePreSSed %
England $. 7.1 -3.6 -3.5
EM 3.6 -1.8 -1.8
E o E 6.4 -5.0 -1.4
(.-4$ 6.7 -3.6 -3.1
L 6.9 -4.0 -2.9
SEC 6.9 -4.8 -2.1
SW 6.4 -6.2 -0.2
TV 8.9 -6.7 -2.2
W 5.0 -3.2 -1.8
WM 1.5 -0.2 -1.3
:5) 7.4 -5.4 -2.1
Total 6.2 -4.0 -2.2
Northern Ireland BHSCT 8.4 -4.7 -3.7
NHSCT 2.2 0.9 -3.1
SEHSCT 3.3 -1.4 -1.9
SHSCT 4.0 -1.3 -2.7
Total 4.9 -2.0 -3.0
Wales ABM 8.7 -4.1 -4.6
AB 8.3 -3.1 -5.2
BC 3.0 4.0 -6.9
$7 5.5 -1.5 -4.1
HD 2.1 -2.6 0.5
Total 6.5 -2.4 -4.1
Other Other 7.1 -7.1 0.0
TOTAL 6.2 -3.8 -2.4
England N=14,165, Northern Ireland N=810, Wales N=1,254, Total N=16,337 (includes Other)
8)4$5$5IBTCFFOSFNPWFEEVFUPJOTVöDJFOU/"$3EBUB
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The following outcome variables have yet to achieve sufficient sample size to allow analysis 
by region or at programme level. However, combining all three nations provides sufficient 
data to report nationally.
Table 25 shows that, after CR, there is a 27 percentage point improvement in meeting the total 
cholesterol target (<4.0), and a 25 percentage point change meeting the LDL target (<2.0). 
Smaller positive changes were also seen for waist circumference (three percentage points), 
blood pressure (two percentage points) and alcohol consumption (one percentage point). 
The Incremental Shuttle Walk Test, which is a valid field test of fitness in CR patients, was 
recorded for 4,363 patients as the primary measure of fitness as part of this report. Following 
CR, 60% of patients achieved the minimum clinical difference of >70m (Table 26). An even 
stronger benefit was seen in the Six Minute Walk Test of walking endurance (aimed at patients 
with HF) which showed that 75% of patients achieved a minimum clinical difference of >25m 
(Table 26). Uncertainty remains about the extent of minimum clinical difference for different 
patient populations. NACR will aim to clarify elements of this in future publications.
Despite BACPR recommendations for the assessment of fitness to classify patients risk and 
inform the exercise prescription prior to CR, less than a third of patients are receiving a 
functional capacity measurement at baseline. This is a requirement of the BACPR minimum 
standards (BACPR 2017) as it aids risk stratification and enables the intervention to be tailored 
to patient need.
analysis of Cr contribution to additional  
cardiovascular risk factors and physical fitness
Table 25:  
ChaNGe iN riSK faCTor ouTCoMeS
Pre % PoST % PoiNT ChaNGe %
Cholesterol (Total) N=3,391 <4.0 34 61 27
Cholesterol (LDL) N=3,391 <2.0 31 56 25
Blood Pressure N=19,815 Systolic <140 and Diastolic <90 69 71 2
Waist N=9,534 <102 cm Male <88cm Female 57 60 3
Alcohol N=13,897 <14 units of alcohol per week 84 85 1
Table 26:  
MeaSureS of WalKiNG fiTNeSS aNd leVel of aChieVeMeNT aGaiNST CliNiCallY MeaNiNGful differeNCeS
No % YeS %
Incremental Shuttle Walk Test N=4,363 Clinical difference of >70m 40 60
(Houchen-Wollof 2015)
Six Minute Walk Test N=2,333 Clinical difference of >25m 25 75
(Gremeaux 2011)
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There was a 2.7, 2.8 and 2.1 percentage point improvement of QoL post-CR in England, 
Northern Ireland and Wales measured by each patient’s positive response to the 
question (Table 27b). There continues to be large improvements in other questions such 
as a total 32.4 percentage point increase in physical fitness and a 5.3 percentage point 
increase in self-perceived pain (Table 27a-b). Variation in the amount of QoL change 
following CR is considerable across Health Regions.
analysis of Cr contribution to normal  
health-related Quality of life
Table 27a: 
PerCeNTaGe of PaTieNTS WiTh NorMal healTh relaTed Qol (darTMouTh CooP) SCore Pre- aNd PoST-Cr
PhYSiCal fiTNeSS feeliNGS dailY aCTiViTeS SoCial aCTiViTieS
CouNTrY healTh reGioN Pre% PoST% Pre% PoST% Pre% PoST% Pre% PoST%
England $. 40.9 75.6 85.1 90.5 85.7 95.2 83.5 93.9
EM 44.7 62.6 86.3 89.3 86.0 89.8 86.3 90.4
E o E 45.6 80.0 86.2 90.4 87.5 96.3 85.9 95.6
(.-4$ 41.3 74.5 85.6 89.6 84.6 96.6 80.2 93.8
L 44.5 76.7 83.7 88.4 84.9 95.3 82.9 93.8
SEC 42.3 80.5 84.7 91.1 82.7 96.1 81.0 95.3
SW 53.3 80.7 85.7 94.8 87.3 97.7 90.0 96.8
TV 55.3 84.5 86.9 89.8 88.4 96.7 84.9 96.5
W 51.2 81.8 89.0 91.8 88.7 96.9 89.1 97.3
WM 27.9 75.5 89.6 92.0 80.1 96.3 79.8 95.2
:5) 26.8 62.2 84.4 89.8 82.3 93.0 82.3 93.7
Total 43.1 75.9 85.6 90.3 85.2 95.4 83.7 94.6
Northern Ireland BHSCT 39.4 73.9 81.1 89.4 88.3 94.3 84.8 94.3
NHSCT 29.3 69.0 91.4 94.8 89.7 96.6 89.7 94.8
SEHSCT 47.8 82.9 87.8 95.1 90.2 98.5 87.3 97.1
SHSCT 20.0 58.8 85.0 91.3 82.5 97.5 81.3 96.3
Total 38.7 74.5 84.9 92.1 88.3 96.4 85.7 95.6
Wales ABM 38.7 71.0 83.3 90.5 84.4 95.5 79.7 95.0
AB 46.9 72.7 82.2 88.7 85.8 94.2 85.5 91.6
BC 38.1 77.1 82.9 87.6 78.1 94.3 80.0 94.3
$7 44.1 71.3 83.8 91.9 88.3 94.3 88.3 96.0
CT 27.8 50.0 83.3 88.9 72.2 100.0 66.7 77.8
HD 38.9 57.4 86.8 88.9 78.9 87.4 81.1 87.9
Total 41.5 69.5 83.7 89.9 83.9 93.6 82.8 93.0
Other Other 66.3 96.5 81.4 93.0 89.5 100.0 91.9 98.8
TOTAL 43.0 75.4 85.4 90.3 85.3 95.3 83.8 94.5
England N=11,918, Northern Ireland N=608, Wales N=1,194, Total N=13,806 (includes Other)
WHSCT has been removed due to insufficient NACR data
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Table 27b:  
PerCeNTaGe of PaTieNTS WiTh NorMal healTh relaTed Qol (darTMouTh CooP) SCore Pre- aNd PoST-Cr
PaiN oVerall healTh SoCial SuPPorT QualiTY of life
CouNTrY healTh reGioN Pre% PoST% Pre% PoST% Pre% PoST% Pre% PoST%
England $. 76.2 80.6 60.3 78.8 89.0 85.4 95.0 98.0
EM 79.4 81.3 64.6 71.3 87.7 85.4 96.4 97.0
E o E 82.2 85.0 69.5 81.4 89.3 85.0 96.2 97.3
(.-4$ 75.5 81.6 60.7 77.8 86.4 84.3 94.6 97.8
L 76.0 82.5 62.4 77.8 84.6 82.7 94.2 97.2
SEC 77.7 85.0 65.2 80.3 89.3 85.3 94.3 98.0
SW 76.6 87.3 66.0 83.7 85.5 83.0 92.5 98.6
TV 82.2 85.5 66.3 82.9 86.7 86.7 96.5 99.2
W 79.5 84.8 69.5 81.9 89.7 85.8 96.8 98.1
WM 81.1 86.2 61.2 82.7 89.1 87.8 95.2 97.9
:5) 73.9 77.2 59.7 72.9 91.5 88.3 93.6 97.3
Total 77.7 83.0 64.1 78.7 87.9 85.0 95.0 97.7
Northern Ireland BHSCT 75.8 81.4 67.4 83.3 88.6 84.8 93.6 96.6
NHSCT 89.7 86.2 67.2 86.2 89.7 89.7 96.6 100.0
SEHSCT 86.8 91.7 68.3 85.4 84.9 83.9 97.1 99.5
SHSCT 80.0 88.8 58.8 86.3 95.0 85.0 95.0 97.5
Total 81.3 86.2 66.4 84.7 88.3 84.9 95.2 98.0
Wales ABM 73.8 81.1 63.5 79.7 86.4 83.6 95.8 96.9
AB 72.7 78.5 64.4 78.2 87.3 86.9 93.8 96.0
BC 81.0 79.0 67.6 81.9 89.5 81.0 92.4 97.1
$7 75.7 83.8 70.9 79.8 85.8 86.2 97.6 98.4
CT 72.2 77.8 55.6 83.3 88.9 83.3 94.4 100.0
HD 70.0 70.5 57.9 67.4 81.6 85.3 92.1 95.8
Total 74.0 79.1 64.6 77.6 86.0 84.9 94.8 96.9
Other Other 74.4 84.9 84.9 93.0 94.2 95.3 96.5 98.8
TOTAL 77.5 82.8 64.3 79.0 87.8 85.1 95.0 97.7
England N=11,918, Northern Ireland N=608, Wales N=1,194, Total N=13,806 (includes Other)
WHSCT has been removed due to insufficient NACR data
21 3 54 6evaluation of Patient outcomes following Cr by Country, health region and local Programme
The NaTioNal audiT of CardiaC rehabiliTaTioN  
aNNuaL STATISTICAL REPORT 2017
64
ParT SiX: 
reCoMMeNdaTioNS  
aNd aCTioNS
The NaTioNal audiT of CardiaC rehabiliTaTioN  
aNNual STaTiSTiCal rePorT 2017
74%
The CoVeraGe of uK Cr 
ProGraMMeS eNTeriNG daTa
74%
65
21 3 54 6 recommendations  and actions
3
24
224
The raNGe of iMProVeMeNTS  
iN PhYSiCal aCTiViTY leVelS  
iN PaTieNTS folloWiNG  
Cr iN 2015-16. 
27%– 
47%
CoVeraGe of rePorTiNG iN 
ThiS Year’S rePorT
Countries
3
Health Regions
24
CR Programmes
224
27%
47%
The NaTioNal audiT of CardiaC rehabiliTaTioN  
aNNuaL STATISTICAL REPORT 2017
66
ParT SiX: reCoMMeNdaTioNS aNd aCTioNS
The NACR 2017 annual report builds on last year’s by evaluating CR delivery and 
performance against national and nation-specific averages in service delivery 
for England, Northern Ireland and Wales. The report highlights some significant 
improvements; however, there is unacceptable variation in the quality of delivery 
and outcomes, which results in a mean national change in patient outcomes ranging 
from 1% to 31%.  
Our analysis reveals that some CR services are improving against service level 
standards with positive patient outcomes, based on national average change, 
and evident across physical, risk factor and psychosocial measures. Based on the 
recommendations set in last year’s report we have seen an increase in females 
attending CR, HF patient numbers increasing and shortening of wait times. However, 
a large proportion of eligible HF and female patients are still failing to attend CR, and 
the menu of CR options is still primarily group-based, not being delivered for long 
enough and patients are not receiving a post-CR assessment.
67
KeY reCoMMeNdaTioNS:
1.  Programmes should aim to recruit a greater proportion of eligible female patients. 
2.  A much bigger proportion of eligible HF patients should be referred to CR and 
supported to take up the offer.
3.  A greater range of modes of delivery, beyond just centre-based, should be  
offered to patients. 
4.  Assessment of patients who complete CR should be at 100%. 
5.  The duration of CR should meet the minimum requirement of eight weeks.
6.  Programmes should seek to have their service accredited as part of the  
National Certification Programme for CR.
aCTioNS:
1.  Greater positive action is required to recruit more female patients which  
is likely to require significant changes to the type and location of CR offered.
2.  Referral of patients with HF should increase in line with clinical recommendations. 
3.  Programmes need to offer and strongly promote a wider portfolio of CR delivery 
options. 
4.  Assessment of patients as they complete their programme should be  
a major priority. 
5.  Services operating below minimum standards should strive to increase  
the duration and frequency of rehab sessions. 
6.  All programmes should contact the NACR team to assess their extent of  
readiness for a possible submission to the National Certification Programme  
for CR. This service is free to NACR users.
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